Equity Overview
Price & Market Data
Price: $0.84
Daily Change: -$0.0085 / 1.01%
Range: $0.804 - $0.898
Market Cap: $65,045,984
Volume: 71,305
Performance Metrics
1 Week: -2.13%
1 Month: -17.48%
3 Months: -9.49%
6 Months: -28.97%
1 Year: -38.56%
YTD: -11.40%
Company Details
Employees: 32
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.